ES2038690T3 - Aminoacidos insaturados. - Google Patents

Aminoacidos insaturados.

Info

Publication number
ES2038690T3
ES2038690T3 ES198787810080T ES87810080T ES2038690T3 ES 2038690 T3 ES2038690 T3 ES 2038690T3 ES 198787810080 T ES198787810080 T ES 198787810080T ES 87810080 T ES87810080 T ES 87810080T ES 2038690 T3 ES2038690 T3 ES 2038690T3
Authority
ES
Spain
Prior art keywords
hydroxyl
alkyl
aroyal
hydrogen
link
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787810080T
Other languages
English (en)
Inventor
Christof Dr. Angst
Derek Edward Dr. Brundish
John Grey Dr. Dingwall
Graham Eric Dr. Fagg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2038690T3 publication Critical patent/ES2038690T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826—Acyclic unsaturated acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302—Acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3217—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

LA INVENCION SE REFIERE A AMINOACIDOS NO SATURADOS DE LA FORMULA (I) EN LA QUE R1 ES HIDROXI O UN HIDROXI ETERIFICADO, R2 ES HIDROGENO, ALQUILO, HIDROXI O HIDROXI ETERIFICADO, R3 ES HIDROGENO, ALQUILO, HALOGENO, HIDROXIALQUILO, ALCOXIALQUILO INFERIOR, ARILALQUILO, ALQUENILO INFERIOR, HALOGENO O ARILO, R4 ES HIDROGENO, ALQUILO O ARILO, R5 ES HIDROGENO O ALQUILO, R6 ES CARBOXI, CARBOXI ESTERIFICADO O AMIDADO, R7 ES AMINO O AMINO SUSTITUIDO POR ALQUILO O ACILO, A ES ALFA-OMEGA-ALQUILENO NO SUSTITUIDO O SUSTITUIDO POR ALQUILO, CON 1 A 3 ATOMOS DE CARBONO O UN ENLACE, B ES METILENO O UN ENLACE, EN LA INTELIGENCIA DE QUE A ES DIFERENTE DE UN ENLACE SI B ES UN ENLACE, ASI COMO SUS SALES. PUEDEN SER OBTENIDAS P.E. SEGUN LA REACCION DE MICHAELIS-ARBUZOV Y SON ACTIVOS FARMACOLOGICAMENTE.
ES198787810080T 1986-02-13 1987-02-10 Aminoacidos insaturados. Expired - Lifetime ES2038690T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH57886 1986-02-13

Publications (1)

Publication Number Publication Date
ES2038690T3 true ES2038690T3 (es) 1993-08-01

Family

ID=4190244

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787810080T Expired - Lifetime ES2038690T3 (es) 1986-02-13 1987-02-10 Aminoacidos insaturados.

Country Status (23)

Country Link
EP (1) EP0233154B1 (es)
JP (2) JPH0717665B2 (es)
KR (1) KR900003533B1 (es)
AT (1) ATE70535T1 (es)
AU (1) AU610493B2 (es)
CA (1) CA1331625C (es)
CY (1) CY1821A (es)
DD (1) DD263775A5 (es)
DE (1) DE3775229D1 (es)
DK (1) DK169341B1 (es)
ES (1) ES2038690T3 (es)
FI (1) FI85144C (es)
GR (1) GR3003526T3 (es)
HK (1) HK95594A (es)
HU (1) HU204532B (es)
IE (1) IE59417B1 (es)
IL (1) IL81543A0 (es)
NO (1) NO170938C (es)
NZ (1) NZ219255A (es)
PH (1) PH23762A (es)
PT (1) PT84270B (es)
SG (1) SG92294G (es)
ZA (1) ZA871022B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175344A (en) * 1986-02-13 1992-12-29 Ciba-Geigy Corporation Unsaturated amino acids
PT85874B (pt) * 1986-10-09 1990-07-31 Ciba Geigy Ag Processo para a preparacao de oligo-peptidos com accao antibiotica
EP0302826A3 (de) * 1987-08-04 1991-04-03 Ciba-Geigy Ag Verfahren zur Herstellung neuer ungesättigter Aminosäureverbindungen
US5175153A (en) * 1987-11-30 1992-12-29 Warner-Lambert Company Substituted alpha-amino acids having pharmaceutical activity
US5179085A (en) * 1989-03-15 1993-01-12 Warner-Lambert Company N-substituted α-amino acids and derivatives thereof having pharmaceutical activity
DE59007300D1 (de) * 1989-04-07 1994-11-03 Ciba Geigy Ag Ungesättigte Aminodicarbonsäurederivate.
US5500419A (en) * 1989-09-19 1996-03-19 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
EP0420806B1 (de) * 1989-09-26 1995-07-05 Ciba-Geigy Ag Phosphonsäure, Verfahren zur Herstellung und Verwendung als Arzneimittelwirkstoff
US5294734A (en) * 1989-09-26 1994-03-15 Ciba-Geigy Corp. 4-substituted 2-aminoalk-3-enoic acids
US5488140A (en) * 1989-09-26 1996-01-30 Ciba-Geigy Corporation 4-substituted 2-aminoalk-3-enoic
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
JPH07505908A (ja) * 1992-09-28 1995-06-29 マックセチーニ、マリア　ルイザ Ｎｍｄａ受容体のアロステリックモジュレーター
CA2626435A1 (en) * 2005-10-18 2007-05-10 Centre National De La Recherche Scientifique (Cnrs) Hypophosphorous acid derivatives and their therapeutical applications
DE102007032669A1 (de) * 2007-07-13 2009-01-15 Clariant International Limited Alkylphosphonigsäuren, -salze und -ester, Verfahren zu deren Herstellung und ihre Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477391A (en) 1981-08-14 1984-10-16 Collins James F Amino acid isomers, their production and their medicinal use
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use

Also Published As

Publication number Publication date
NO170938B (no) 1992-09-21
HK95594A (en) 1994-09-16
HU204532B (en) 1992-01-28
IL81543A0 (en) 1987-09-16
KR870007942A (ko) 1987-09-23
PH23762A (en) 1989-11-03
DK70787D0 (da) 1987-02-12
NO170938C (no) 1992-12-30
FI85144B (fi) 1991-11-29
FI85144C (fi) 1992-03-10
NO870577L (no) 1987-08-14
HUT43863A (en) 1987-12-28
FI870558A0 (fi) 1987-02-11
EP0233154A3 (en) 1989-06-14
FI870558A7 (fi) 1987-08-14
DE3775229D1 (de) 1992-01-30
NO870577D0 (no) 1987-02-13
IE870365L (en) 1987-08-13
PT84270B (pt) 1989-09-14
JPH07206683A (ja) 1995-08-08
GR3003526T3 (es) 1993-03-16
JPH0717665B2 (ja) 1995-03-01
CY1821A (en) 1995-10-20
DK169341B1 (da) 1994-10-10
EP0233154B1 (de) 1991-12-18
IE59417B1 (en) 1994-02-23
JPS62246586A (ja) 1987-10-27
SG92294G (en) 1995-04-28
EP0233154A2 (de) 1987-08-19
ZA871022B (en) 1987-09-30
CA1331625C (en) 1994-08-23
NZ219255A (en) 1989-08-29
AU6872687A (en) 1987-08-20
JP2509465B2 (ja) 1996-06-19
KR900003533B1 (ko) 1990-05-21
PT84270A (en) 1987-03-01
DK70787A (da) 1987-08-14
ATE70535T1 (de) 1992-01-15
AU610493B2 (en) 1991-05-23
DD263775A5 (de) 1989-01-11

Similar Documents

Publication Publication Date Title
ES2033715T3 (es) Un procedimiento para producir un derivado de 2-fenoxipirimidina.
ES2121836T3 (es) Aminoguanidinas.
CO4560411A1 (es) Nuevas oxazolidinonas sustituidas
ES2064700T3 (es) Derivados de adenosina con actividad farmaceutica como antihipertensivos.
FR2498187B1 (es)
MX165512B (es) Aditivo de carbamato para composicion lubricante
ES2177248T3 (es) Poliamida inherentemente foto- y termo-estabilizada y procedimiento para su preparacion.
ES2038622T3 (es) Utilizacion de un derivado de naftaleno y su procedimiento de preparacion.
AR245933A1 (es) Procedimiento para preparar compuestos de 4-(3-hidroxifenil)metil-3-alquil-n-alquilpiperidina y sus sales.
ES2130736T3 (es) Derivados del pirrolilbencimidazol.
AR241082A2 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
ES2031510T3 (es) N-fenil-butenamidas con propiedades farmaceuticas.
CO4830475A1 (es) Composicion lubricante
ES2087936T3 (es) Benceno, piridina y derivado de pirimidina.
ES2070238T3 (es) Emulsion de lipidos que contiene un analogo de prostaglandina.
ES2009785B3 (es) Procedimiento para preparar derivados de tioxantona.
KR860000293A (ko) 함암작용을 갖는 푸란유도체의 제조방법
TW427979B (en) A condensed piperidine compound
ES2151254T3 (es) Derivados de 2-(3h)-oxazolona y su uso como inhibidores de cox-2.
ES2192584T3 (es) Derivado pirimidinilpirazol.
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
ES2103161B1 (es) Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos.
ES2053865T5 (es) Utilizacion de compuestos etanosulfonicos 2-substituidos como productos galvanotecnicos auxiliares.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 233154

Country of ref document: ES